Sarepta Therapeutics, Inc. (SRPT) Discusses Preliminary Phase I/II Data for SRP-1001 in FSHD1 and SRP-1003 in DM1 Transcript

March 25, 2026 05:35:55 pm

Source: SeekingAlpha

2026-03-25 17:35:55 ET

Sarepta Therapeutics, Inc. (SRPT) Discusses Preliminary Phase I/II Data for SRP-1001 in FSHD1 and SRP-1003 in DM1 March 25, 2026 8:30 AM EDT...

For further details see:

Sarepta Therapeutics Inc.

3.06% G/L:

$23.21 Last:

1,180,802 Volume:

$21.93 Open:

March 25, 2026 08:05:00 am

March 24, 2026 04:05:00 pm

March 21, 2026 04:20:00 pm

March 19, 2026 08:30:00 am

Market Cap $1,921,797,010

Float 96,823,361

Insiders Ownership N/A

Institutions 132

Short Percent N/A

Industry Biotechnology & Life Sciences

Sector Healthcare

Country US

City Cambridge